AGIO Crosses Above Average Analyst Target
June 04, 2024 at 06:52 AM EDT
In recent trading, shares of Agios Pharmaceuticals Inc (AGIO) have crossed above the average analyst 12-month target price of $43.00, changing hands for $43.83/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..